Optimizing Dyslipidemic Cardiovascular Residual Risk Reduction With Icosapent Ethyl in Post-MI Patients. Boden WE, Andersson C. J Am Coll Cardiol 2022;79:1672-1674.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boden WE, Andersson C. Optimizing Dyslipidemic Cardiovascular Residual Risk Reduction With Icosapent Ethyl in Post-MI Patients. J Am Coll Cardiol 2022;79:1672-1674.
PMID: 35483754